Harrow Inc (HROW)
followers
·
Follow
| Sector: | HEALTH CARE |
| Industry: | PHARMACEUTICALS |
| SIC: | PHARMACEUTICAL PREPARATIONS |
| CEO: | Mark L. Baum |
| Employees: | 180 |
| Web site: | harrowinc.com |
|
102 WOODMONT BLVD, SUITE 610, NASHVILLE, TN, 37215
615.733.4731
| |
-
Formally known as:
- IMPRIMIS PHARMACEUTICALS, INC. NEW
- TRANSDEL PHARMACEUTICALS, INC
| Date | Ratio |
|---|---|
| 2007-09-21 | 0.4625:1 |
| 2012-02-24 | 1:8 |
| 2013-02-08 | 1:5 |
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
Harrow Health, Inc. owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company that focuses on development and commercialization of therapeutics for ocular surface diseases.
Please log in first to see chart